The purpose of the Apremilast Pregnancy Exposure Registry is to monitor planned and unplanned pregnancies exposed to apremilast and to evaluate the safety of this medication relative to specified pregnancy outcomes, and to evaluate potential effects of prenatal apremilast exposure on infant health status through one year of age.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The number of major structural malformations identified in the children of study participants
Timeframe: Throughout pregnancy through 1 year of life
A pattern of major malformations identified in the children of study participants
Timeframe: Throughout pregnancy through 1 year of life